Antigingivitis/Antiplaque Combination With Other Actives Excluded In ANPR
This article was originally published in The Tan Sheet
Executive Summary
FDA's advance notice of proposed rulemaking for OTC antigingivitis/antiplaque products excludes the combination of antigingivitis/antiplaque ingredients with other oral health care ingredients. The 1notice was published in the May 29 Federal Register
You may also be interested in...
Colgate Bids To Expand U.S. Toothpaste Lineup Through FDA Rulemaking
Colgate seeks regulatory approval for a version of its Colgate Sensitive Multi-Protection toothpaste in a formulation it already markets internationally. The request made in a citizen petition comes after Colgate’s plan to expand its U.S. toothpaste business failed when FDA did not give approval for Sensitive Pro-Relief.
P&G, Pfizer Disagree On Antiplaque Claims Support, Stannous Fluoride
Procter & Gamble and Pfizer take opposing views on the way therapeutic stand-alone antiplaque claims should be regulated in comments submitted to FDA Feb. 20
P&G, Pfizer Disagree On Antiplaque Claims Support, Stannous Fluoride
Procter & Gamble and Pfizer take opposing views on the way therapeutic stand-alone antiplaque claims should be regulated in comments submitted to FDA Feb. 20